Definium Therapeutics, Inc. (NASDAQ:DFTX) Q1 2026 Earnings Call Transcript

Definium Therapeutics, Inc. (NASDAQ:DFTX) Q1 2026 Earnings Call Transcript May 7, 2026

Definium Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.71 EPS, expectations were $-0.49213.

Gita Jain: Good afternoon. I am Gita Jain, Head of Investor Relations, and thank you for joining us today for Mind Medicine (MindMed) Inc.’s first quarter 2026 financial results and recent highlights conference call. Currently, all participants are in listen-only mode. This webcast is...